This inventor holds 1 USPTO granted patent. Top assignee: Rznomics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tae Young Kim: Innovator in Cancer Research
Introduction
Tae Young Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of cancer research through his innovative work. His dedication to advancing medical science is evident in his patented inventions.
Latest Patents
Tae Young Kim holds a patent for a groundbreaking invention titled "Cancer-Specific Trans-Splicing Ribozyme Expressing Immune Checkpoint Inhibitor, and Use Thereof." This patent represents a significant advancement in cancer treatment, focusing on immune checkpoint inhibitors that can specifically target cancer cells.
Career Highlights
Currently, Tae Young Kim is associated with Rznomics Inc., a company dedicated to developing innovative therapeutic solutions. His work at Rznomics Inc. highlights his commitment to translating scientific research into practical applications that can benefit patients.
Collaborations
Tae Young Kim collaborates with Seong-Wook Lee, a fellow researcher, to further enhance their contributions to cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.
Conclusion
Tae Young Kim's contributions to cancer research through his patent and work at Rznomics Inc. underscore his role as a key innovator in the field. His efforts are paving the way for new therapeutic approaches that could significantly impact cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile